Latest Capital Raises News

Lightning Minerals has appointed Troy Brice as CEO, bringing seasoned leadership to spearhead the next phase of exploration at its Mt Turner Gold Project.

Novo Resources has officially listed over 25 million free-attaching options on the ASX, following its recent capital raising. These options, exercisable at 15 cents, underpin the company’s ongoing exploration ambitions across Western Australia and New South Wales.

Caspin Resources has successfully completed a $6 million placement and exercised options, bolstering its position in promising Australian mineral projects focused on tin and gold.

Imricor Medical Systems has filed a Form 10 registration with the U.S. SEC, marking its transition to a U.S. reporting company amid ongoing FDA clearances and clinical trials. This move signals a significant step in its early commercialisation of MRI-guided cardiac ablation technology.

Star Minerals has completed the sale of its West Bryah copper-gold project to Catalyst Metals for $2.75 million, including cash and shares, while Catalyst also takes a strategic stake in Star Minerals. This move strengthens Star Minerals’ focus on advancing its Tumblegum South Gold Project.

Chimeric Therapeutics Limited has announced a significant 100-to-1 security consolidation affecting shares, options, and performance rights, pending shareholder approval and set for implementation in April 2026.

EBR Systems marked a pivotal transition in 2025 with FDA approval of its WiSE CRT System and the initiation of U.S. commercial implants, generating $1.6 million in revenue. Despite this progress, the company reported a net loss of $48.8 million and completed a significant capital raise to support ongoing growth.

Alligator Energy has appointed Dr Andrea Marsland-Smith as Managing Director in addition to her CEO role, while preparing for the retirement of veteran Non-Executive Director Peter McIntyre following a key project milestone.

ChemX Materials has formalised a $1.2 million unsecured loan with independent investor Ovay Pty Ltd to support its working capital amid ongoing restructuring, with the loan set to convert to shares upon re-listing.

EVE Health Group has increased its placement funding to $1.3 million, backed by a cornerstone investor with pharmaceutical expertise, advancing its reformulated drug programs targeting billion-dollar global markets.

Core Lithium has taken the final investment decision to restart its Finniss Lithium Project, backed by a $307 million diversified funding package and strategic partnerships. The project targets a 20-year mine life with low operating costs and significant growth potential.

Anax Metals has successfully raised $10 million through a two-tranche placement, strengthening its financial position ahead of critical funding and development milestones for the Whim Creek Copper Project.